WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'2201 Infant (under 12 months) mortality rate: 172
GDP / capita (US$): 9'1841 Child (under 5 years) mortality rate: 202

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 6'811  6'725  6'639  6'553  6'466  5'303  4'214  3'181 
Births 141  141  140  140  140  143  141  117 
Surviving infants 137  137  137  136  136  138  135  111 
Pop. less than 5 years 674  672  674  675  680  705  654  508 
Pop. less than 15 years 2'002  1'999  2'001  2'003  2'011  2'027  1'738  1'352 
Female 15-49 years 1'787  1'762  1'734  1'706  1'676  1'286  980  720 

Number of reported cases

(Click for retrospective incidence data for Paraguay)
Diphtheria
ChartChart
  10  14 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  1'396  745 
Mumps
ChartChart
  1'090  286  178  147  172  527 
Pertussis
ChartChart
  44  31  32  101  81  24  115  652 
Polio*
ChartChart
 
Rubella
ChartChart
  96 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  38  99 
Tetanus (total)**
ChartChart
  10  13  50  188 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Paraguay)
Vaccine year result method % card seen                                                
BCG 2015  96  MICS   89  84  82  84  77  72  79  92  31 
DTP1 2015  96  MICS   89  83  82  84  78  73  73 
DTP3 2015  90  MICS   89  79  93  80  74  73  80  80  17 
DTP4          69  69  64  61 
IPV1          83  83 
HepB_BD          52  78 
HepB3 2015  90  MICS   89  79  80  80  74  73 
Hib3 2015  90  MICS   89  79  80  80  74  73 
JapEnc         
MCV1          80  91  66  72  75  92  71  19 
MCV2          70  75  60  64  64 
MenA         
PCV1          97  83  84  78  73 
PCV2          69  83  81  76  74 
PCV3 2014  85  MICS   89  78  85  75  71  81 
Pol3 2015  91  MICS   89  79  80  80  74  71  73  78  13 
Rota1          83  81  83  75  71 
RotaC 2015  91  MICS   89  81  79  79  72  70 
RCV1          80  91  66  73  75 
TT2plus 2015  69  MICS   89  29  55  29 
PAB         
VAD1         
YFV 2014  85  MICS   89  79  80  71  63  80 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Paraguay)
BCG
ChartChart
  99  99  95  90  85  75  31 
DTP1
ChartChart
  99  99  98  93  95  86  40 
DTP3
ChartChart
  93  93  87  86  86  67  17 
HepB3
ChartChart
  93  93  87  86 
HepB_BD
ChartChart
 
Hib3
ChartChart
  93  93  87  86 
IPV1
 
MCV1
ChartChart
  83  83  89  92  92  69  19 
MCV2
ChartChart
  77  77  81  81 
PCV3
ChartChart
  92  92  88  90 
Pol3
ChartChart
  89  89  83  80  86  64  14 
RCV1
ChartChart
  83  83  89  92  92 
RotaC
ChartChart
  92  92  85  83 
YFV
ChartChart
  99  99  95  97 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 249  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 21
From 80 to 89% 17
From 50 to 79% 51
Less than 50% 10
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepA_Adult 1st contact; risk groups
HepA_Pediatric 15 months; Yes
HepB_Adult Yes risk groups
HepB_Pediatric births; Yes
HIB 1st contact; Yes immunocompromized
HPV 10 years; +6 months; Yes females
Influenza_Adult >=60 years; Yes and adults with chronic illness, pregnant women, health care workers, Haj and other travellers, other risk groups
Influenza_Pediatric 6-35 months; Yes and children with chronic illness
IPV 2 months; Yes and children with immodeficiency or children of parents with full HIV outline
MenACWY-135 conj 1st contact; Yes immunodeficiencies, travellers, risk prevention of outbreaks
MMR 1, 4 years; Yes
MR 1st contact; Yes populations of risk for imported cases, puerperals seronegative for MR
OPV 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >=60 years Yes risk groups
Rotavirus 2, 4, 6 months; Yes
Td Yes every 10 years
Tdap 10 years; Yes and pregnant women, HCWs
Tetanus 1st contact; Yes
Varicella 15 months; Yes and risk groups
YF 12 months; Yes until 59 years if not vaccinated, travellers, HCWs

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2014-2018  2014-2018  2'014  2'014  2012-2016  2012-2016  2012-2016 
Nº of districts with microplans that include activities to raise immunization coverage number 249  249    245  241  240  238 

System performance

Total Nº districts in country number 249  249  250  245  241  240  238 
Nº districts with DTP3 coverage >=80% number 96  99  98  81  78  86  87 
% of districts with DTP3 coverage >=80% From 0 to 100% 39  40  39  33  32  36  37 
Nº districts with measles (MCV1) coverage >=95% number 33  74  11  24  33  27  39 
% of districts with MCV1 coverage >=95% From 0 to 100% 13  30  10  14  11  16 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100    99  97 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.